Long-Acting Beta-Agonists Market

Future Market Insights

Key Insight

The long-acting beta-agonists market is projected to grow from USD 8.8 billion in 2025 to USD 18.0 billion by 2035, at a CAGR of 7.4%. Salmeterol will dominate with a 40.0% market share, while inhaled will lead the formulation segment with a 50.0% share.

October 15, 2025

Anurag Sharma

275 Pages

Cite this Report

Long-Acting Beta-Agonists Market

https://www.futuremarketinsights.com/reports/long-acting-beta-agonists-market

License

Buy Now

Summary ToC Companies

Key Players

BlackRock
Boehringer Ingelheim
Chiesi Farmaceutici S.p.A
GlaxoSmithKline plc (GSK)
Merck KGaA
Novartis
Organon & Co
Berkshire Hathaway

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Long-Acting Beta-Agonists Market

Key Players

Similar Industry Reports